Software & Data
Amazon Gets Specific In Healthcare Machine Learning
Jeff Bezos is well known for his willingness to take risk and make bold bets on new endeavors. He once stated that he has lost billions of dollars trying out new ideas or acquiring companies. With those risks, however, comes much deliberation and calculation of possible outcomes. And with healthcare, Amazon is playing it particularly smart by sponsoring and teaming up with targeted healthcare players to put its technology to use...
Medical Devices
3M Acquires Acelity And Its KCI Subsidiaries For $6.7bn
3M, the industrial products and consumer goods giant announced that it recently completed the acquisition of global medical tech company, Acelity, Inc under the Kinetic Concepts and Systagenix brands...
Consumer Internet
What Google’s $2.1 Billion Acquisition of Fitbit Means
Following days of rumors, Fitbit announced last week that it is set to be acquired by Google for $7.35 per share. The $2.1 billion all-cash deal will bring the wearables pioneer into the Google suite of companies--but what exactly does the deal mean for the burgeoning wearables market?...
Biotech
Extending Human Life Becoming A Reality
Most in the healthcare industry have begun to hear more about longevity – an area of medical science that has the ability to dramatically improve well-being for all of humanity. With the advancements in understanding human biology at the cellular level, researchers and scientists have pinpointed specific areas that can be treated to improve or extend critical bodily functions. One of the organizations that is pioneering new technology in the longevity space is Juvenescence, a biopharmaceutical company that has raised over $100 million to build a pipeline of therapeutic assets...
Features
DNA Sequencing Leader Illumina Eyes Its Next Move: Distributed Diagnostics
Investors have seen no shortage of big watershed moments from DNA sequencing pioneer Illumina in recent years. The company's announcements of its refrigerator-sized human genome sequencing machines and its symbolic $1,000 human genome have grabbed the attention of observers and investors alike...
Popular Articles
Top 50 Healthcare Technology CEOs of 2019
The Healthcare Technology Report is pleased to announce the Top 50 Healthcare Technology CEOs of 2019. An extensive process was run to evaluate the...
The Top 25 Medical Device Executives of 2019
The Healthcare Technology Report is pleased to announced The Top 25 Medical Device Executives of 2019. This is our inaugural year publishing this awards...
The Top 25 Women Leaders In Biotech of 2019
The Healthcare Technology Report is pleased to announce and recognize a unique set of accomplished women playing vital roles in some of the most...
Top 25 Women Leaders In Healthcare Software of 2019
We are delighted to recognize and celebrate the accomplishments of 2019's Top 25 Women Leaders in Healthcare Software. These women have demonstrated a track...
Alex Gorsky Is The All-American CEO
Alex Gorsky is having a bad year. As chief executive officer of pharmaceutical giant Johnson & Johnson (J&J), he’s been on the hot seat...
Google Health Tech Titan Aashima Gupta Advances The Field
Aashima Gupta works at the intersection of health and technology. As director of global healthcare solutions for Google Cloud, it is her job to...
The 5 Emerging Technologies Poised to Impact Healthcare
Advancements in healthcare technology continue to drive incredible innovation throughout the sector, and certain emerging technologies outside of healthcare are poised to generate even more breakthroughs in digital health. Here are the five technological trends most likely to impact future healthcare...
Thermo Fisher Scientific CEO Marc Casper Makes a Strong Impression
There is much ado about Marc Casper. By all accounts, the CEO of Thermo Fisher Scientific is whip-smart and has a keen eye for what’s happening next in the biotech business but may leave something to be desired when it comes to up-keeping employee morale. Overall, however, under his stewardship the company continues to thrive...
Baxter International Acquires True Process
True Process, a medical software business based in Wisconsin, has found itself a buyer in Fortune 500 medical equipment firm Baxter International. After they...
The Biotech Scene is About Get a Whole Lot Bigger in NYC
New York City may join the upper ranks of some of the leading biotech cities like Boston Raleigh-Durham, and San Francisco with the opening of a new life sciences campus in 2021. Backed by investment group, Deerfield Management, the $635 million project, in partnership with the New York City Economic Development Corporation (NYCEDC), the approximately 300,000-square-foot life sciences space will be in housed within a 12-story building in Midtown Manhattan, and will include more than 200,000 square-feet of the space dedicated to wet labs...
